Shree Ganesh Remedies Ltd - 540737 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the above subject matter we are submitting herewith the confirmation certificate in terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 received from Big-share Services Private Limited, Registrar and Share Transfer Agent for the quarter ended on June 30, 2020. Shree Ganesh Remedies Ltd - 540737 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- ADITYA VIKRAMBHAI PATELDesignation :- Company Secretary and Compliance Officer Shree Ganesh Remedies Ltd - 540737 - Board Meeting Intimation for Revision In Intimation Of Board Meeting (With Respect To Date) Made On June 19, 2020 For The Board Meeting To Be Held On Tuesday, June 30, 2020.
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2020 ,inter alia, to consider and approve With reference to the captioned subject, please take note that the meeting of the Board of Directors of the Company scheduled to be held on Tuesday, June 30, 2020 at the registered office of the Company situated at Ankleshwar is now rescheduled to Friday, July 31, 2020 to consider, amongst other business, the followings ; i. Approval of Audited Financial Results of the Company for the half year and Financial Year ended on 31st March, 20 20. ii. Recommendation of Final Dividend on the Equity Shares, if any. Further in accordance with our intimation dated March 3 0, 2020 regarding Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, the "Trading Window" for trading / dealing in the securities of the Company shall continue to remain closed until 48 hours after the declaration of financial results for the half year and year ended on March 31 , 2020. Shree Ganesh Remedies Ltd - 540737 - Corporate Action-Board to consider Dividend
Recommendation of Final Dividend on the Equity Shares, if any at the Board Meeting to be held on June 30, 2020. Shree Ganesh Remedies Ltd - 540737 - Board Meeting Intimation for I. Approval Of Audited Financial Results Of The Company For The Year Ended March 31, 2020 And Ii. Recommendation Of Final Dividend On The Equity Shares, If Any.
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve i. Approval of Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2020. ii. Recommendation of Final Dividend on the Equity Shares, if any. Shree Ganesh Remedies Ltd - 540737 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayShree Ganesh Remedies Ltd 2CINL24230GJ1995PLC025661 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 2.31 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: ADITYA VIKRAMBHAI PATEL Designation: COMPANY SECRETARY EmailId: investors@ganeshremedies.com Name of the Chief Financial Officer: SURESHBHAI DALSUKHBHAI PANCHAL Designation: CHIEF FINANCIAL OFFICER EmailId: investors@ganeshremedies.com Date: 18/06/2020 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Shree Ganesh Remedies Ltd - 540737 - IMPACT OF COVID-19 PANDEMIC ON OPERATIONS OF THE COMPANY
The lock-downs and restrictions imposed on various activities due to COVID - 19 pandemic, while being a necessary measure to contain its spread, have also posed unprecedented challenges to all businesses and the business operations at Shree Ganesh Remedies Limited (hereinafter referred to as the "Company" or "SGRL") have been no exception to this. The Company''s management has made assessment of likely material adverse impact on business and financial risks and believes that the impact will likely to be short term in nature. Further, as desired by the SEBI circular number SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, the Company is submitting the following details to the extent possible: Shree Ganesh Remedies Ltd - 540737 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In continuation to the intimation made to the stock exchange by the Company on December 24, 2019, we would like to inform you that, the Company has decided to succeed the Business of the Partnership Firm Ashok Pharma Chem (Firm where Company along with it''s nominee owns entire partnership interest) as a going concern. Shree Ganesh Remedies Ltd - 540737 - Restarting Of Plant Operations
We refer to our earlier announcement dated March 24, 2020 regarding temporary suspension of operations at all plants and offices due to lockdown orders issued by various Government Authorities for containment of Covid19 pandemic. Further to above, we would like to inform that the Company has received requisite approvals from the concerned Government Authorities for re-starting operations. The Company has already stared billing. The manufacturing shall be started in a phased manner. Shree Ganesh Remedies Ltd - 540737 - Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 For Half Year Ended On March 31, 2020.
Certificate under Regulation 40 (9) of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 for half year ended on March 31, 2020.